FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Nancy Lewis

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Physiology

Myelopoiesis

Anatomy

Myeloid Progenitor Cells

Co-author Network

Publications

TOP 3
M Dror Michaelson; A Nieto; I Pardos; C A Stein; J Bellmunt; M Cullell-Young; S Goel; Gary R Hudes; Carmen Kahatt; Philip W Kantoff; P Lardelli; R J Lee; Nancy L Lewis; Matthew R Smith
Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancer.
Nancy L Lewis; Lionel D Lewis; Joseph P Eder; Nandi J Reddy; Feng Guo; Kristen J Pierce; Anthony J Olszanski; Roger B Cohen
Phase I study of the safety, tolerability, and pharmacokinetics of oral CP-868,596, a highly specific platelet-derived growth factor receptor tyrosine kinase inhibitor in patients with advanced cancers.
Steven J Cohen; Paul F Engstrom; Nancy L Lewis; Corey J Langer; Susan McLaughlin; Mary Beard; Louis M Weiner; Neal J Meropol
Phase I study of capecitabine and oxaliplatin in combination with the proteasome inhibitor bortezomib in patients with advanced solid tumors.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Nancy Lewis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: M Dror Michaelson; A Nieto; I Pardos; C A Stein; J Bellmunt; M Cullell-Young; S Goel; Gary R Hudes; Carmen Kahatt; Philip W Kantoff; P Lardelli; R J Lee; Nancy L Lewis; Matthew R Smith
Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2012;23(5):1234-40.
2009: Nancy L Lewis; Lionel D Lewis; Joseph P Eder; Nandi J Reddy; Feng Guo; Kristen J Pierce; Anthony J Olszanski; Roger B Cohen
Phase I study of the safety, tolerability, and pharmacokinetics of oral CP-868,596, a highly specific platelet-derived growth factor receptor tyrosine kinase inhibitor in patients with advanced cancers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(31):5262-9.
2008: Steven J Cohen; Paul F Engstrom; Nancy L Lewis; Corey J Langer; Susan McLaughlin; Mary Beard; Louis M Weiner; Neal J Meropol
Phase I study of capecitabine and oxaliplatin in combination with the proteasome inhibitor bortezomib in patients with advanced solid tumors.
American journal of clinical oncology 2008;31(1):1-5.
2007: Nancy L Lewis
The platelet-derived growth factor receptor as a therapeutic target.
Current oncology reports 2007;9(2):89-95.
2006: Steven J Cohen; R Katherine Alpaugh; Steve Gross; S Mark O'Hara; Denis A Smirnov; Leon W M M Terstappen; W Jeffrey Allard; Maryann Bilbee; Jonathan D Cheng; John P Hoffman; Nancy L Lewis; Ann Pellegrino; André Rogatko; Elin R Sigurdson; Hao Wang; James C Watson; Louis M Weiner; Neal J Meropol
Isolation and characterization of circulating tumor cells in patients with metastatic colorectal cancer.
Clinical colorectal cancer 2006;6(2):125-32.
2004: Steven J Cohen; James Gallo; Nancy L Lewis; R Katherine Alpaugh; Louis Gentner; André Rogatko; Gwen Yeslow; Jessie Schol; Tom Verhaeghe; Peter Zannikos; Peter A Palmer; Louis M Weiner; Neal J Meropol
Phase I and pharmacokinetic study of the farnesyltransferase inhibitor R115777 in combination with irinotecan in patients with advanced cancer.
Cancer chemotherapy and pharmacology 2004;53(6):513-8.
2004: Nancy L Lewis; M Mullaney; Kenneth F Mangan; Thomas R Klumpp; André Rogatko; Dominique Broccoli
Measurable immune dysfunction and telomere attrition in long-term allogeneic transplant recipients.
Bone marrow transplantation 2004;33(1):71-8.
2003: Nancy L Lewis; Neal J Meropol
Development of new agents for the treatment of advanced colorectal cancer.
Clinical colorectal cancer 2003;3(3):154-64.
2003: Steven J Cohen; Linus Ho; Sulabha Ranganathan; James L Abbruzzese; R Katherine Alpaugh; Mary Beard; Nancy L Lewis; Susan McLaughlin; André Rogatko; Juan Jose Perez-Ruixo; Amanda M Thistle; Tom Verhaeghe; Hao Wang; Louis M Weiner; John J Wright; Gary R Hudes; Neal J Meropol
Phase II and pharmacodynamic study of the farnesyltransferase inhibitor R115777 as initial therapy in patients with metastatic pancreatic adenocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1301-6.
2002: Nancy L Lewis; Richard Scher; James M Gallo; Paul F Engstrom; Christine E Szarka; Samuel Litwin; Andrea L Adams; Deborah Kilpatrick; Diane Brady; Louis M Weiner; Neal J Meropol
Phase I and pharmacokinetic study of irinotecan in combination with raltitrexed.
Cancer chemotherapy and pharmacology 2002;50(4):257-65.
2000: Nancy L Lewis; Neal J Meropol
Oral fluoropyrimidines in cancer treatment.
Cancer investigation 2000;18(8):747-60.